Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alcoholism | 14 | 2021 | 1980 | 1.360 |
Why?
|
Neurofibromatosis 1 | 14 | 2022 | 561 | 1.350 |
Why?
|
Neurofibromatosis 2 | 12 | 2018 | 387 | 1.040 |
Why?
|
Neurofibromatoses | 9 | 2021 | 303 | 0.890 |
Why?
|
Neurofibroma, Plexiform | 5 | 2022 | 66 | 0.820 |
Why?
|
Neurilemmoma | 8 | 2021 | 522 | 0.720 |
Why?
|
Autistic Disorder | 7 | 2010 | 1239 | 0.620 |
Why?
|
Language Disorders | 3 | 2010 | 140 | 0.600 |
Why?
|
Sex Characteristics | 7 | 2018 | 2647 | 0.600 |
Why?
|
Imaging, Three-Dimensional | 12 | 2023 | 4052 | 0.570 |
Why?
|
Diagnostic Imaging | 7 | 2022 | 3530 | 0.570 |
Why?
|
Neuroma, Acoustic | 6 | 2014 | 455 | 0.560 |
Why?
|
User-Computer Interface | 2 | 2020 | 1411 | 0.520 |
Why?
|
Cerebrovascular Circulation | 18 | 2019 | 2672 | 0.520 |
Why?
|
Magnetic Resonance Imaging | 59 | 2022 | 36582 | 0.520 |
Why?
|
Brain | 28 | 2021 | 27163 | 0.460 |
Why?
|
Frontal Lobe | 12 | 2019 | 1408 | 0.460 |
Why?
|
Cerebral Angiography | 10 | 2014 | 1263 | 0.450 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 18 | 2000 | 1142 | 0.440 |
Why?
|
Basal Ganglia | 8 | 1999 | 549 | 0.410 |
Why?
|
Tomography, X-Ray Computed | 27 | 2023 | 20741 | 0.410 |
Why?
|
Nerve Sheath Neoplasms | 3 | 2022 | 169 | 0.390 |
Why?
|
Cerebellum | 4 | 2016 | 1521 | 0.380 |
Why?
|
Colonography, Computed Tomographic | 2 | 2010 | 170 | 0.370 |
Why?
|
Clinical Trials as Topic | 9 | 2018 | 8048 | 0.350 |
Why?
|
Huntington Disease | 5 | 1999 | 1147 | 0.330 |
Why?
|
Diffusion Tensor Imaging | 3 | 2018 | 2421 | 0.320 |
Why?
|
Whole Body Imaging | 6 | 2020 | 283 | 0.320 |
Why?
|
Receptors, Muscarinic | 1 | 2009 | 156 | 0.320 |
Why?
|
Ethanol | 2 | 2019 | 1330 | 0.310 |
Why?
|
Reward | 3 | 2017 | 980 | 0.310 |
Why?
|
Central Nervous System Depressants | 1 | 2009 | 163 | 0.310 |
Why?
|
Tumor Burden | 8 | 2022 | 1903 | 0.300 |
Why?
|
Radiographic Image Enhancement | 5 | 2010 | 877 | 0.300 |
Why?
|
Contrast Media | 11 | 2023 | 5329 | 0.290 |
Why?
|
Brain Ischemia | 7 | 2019 | 3001 | 0.290 |
Why?
|
Brain Infarction | 3 | 2018 | 285 | 0.290 |
Why?
|
Orbital Diseases | 2 | 2000 | 178 | 0.290 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2023 | 1233 | 0.280 |
Why?
|
Brain Neoplasms | 9 | 2020 | 9108 | 0.260 |
Why?
|
Stroke | 14 | 2019 | 9746 | 0.260 |
Why?
|
Orbit | 2 | 2000 | 459 | 0.260 |
Why?
|
Limbic System | 1 | 2008 | 418 | 0.250 |
Why?
|
Computational Biology | 1 | 2017 | 3567 | 0.250 |
Why?
|
Skin Neoplasms | 7 | 2021 | 5859 | 0.250 |
Why?
|
Neurofibroma | 2 | 2022 | 95 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 13 | 2023 | 8940 | 0.240 |
Why?
|
Functional Laterality | 9 | 2017 | 2245 | 0.230 |
Why?
|
Feces | 2 | 2010 | 1508 | 0.220 |
Why?
|
Brain Mapping | 11 | 2019 | 6597 | 0.220 |
Why?
|
Language | 3 | 2017 | 1550 | 0.220 |
Why?
|
Hippocampus | 3 | 2020 | 3777 | 0.210 |
Why?
|
Cerebral Cortex | 13 | 2004 | 5754 | 0.210 |
Why?
|
Image Enhancement | 2 | 2008 | 2867 | 0.210 |
Why?
|
Temperance | 2 | 2000 | 88 | 0.200 |
Why?
|
Neoplasms | 4 | 2020 | 22350 | 0.200 |
Why?
|
Middle Aged | 65 | 2023 | 223233 | 0.190 |
Why?
|
Tissue Plasminogen Activator | 3 | 2018 | 1164 | 0.190 |
Why?
|
Cerebellar Cortex | 3 | 2010 | 108 | 0.190 |
Why?
|
Blood Volume | 4 | 2001 | 543 | 0.190 |
Why?
|
Axons | 1 | 2009 | 1675 | 0.190 |
Why?
|
Arthrogryposis | 1 | 2022 | 69 | 0.190 |
Why?
|
Humans | 129 | 2023 | 767040 | 0.190 |
Why?
|
Caudate Nucleus | 6 | 2003 | 388 | 0.180 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2019 | 2811 | 0.180 |
Why?
|
Organ Size | 6 | 2020 | 2264 | 0.180 |
Why?
|
Adult | 62 | 2023 | 223317 | 0.170 |
Why?
|
Male | 85 | 2021 | 364203 | 0.170 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 3370 | 0.170 |
Why?
|
Periosteum | 1 | 2000 | 139 | 0.170 |
Why?
|
Cerebrospinal Fluid | 2 | 1994 | 540 | 0.170 |
Why?
|
Quinazolines | 3 | 2013 | 1369 | 0.160 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2009 | 485 | 0.160 |
Why?
|
Thrombolytic Therapy | 6 | 2018 | 2054 | 0.160 |
Why?
|
AIDS Dementia Complex | 3 | 1995 | 154 | 0.160 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2000 | 354 | 0.160 |
Why?
|
Orbital Fractures | 1 | 2000 | 108 | 0.160 |
Why?
|
Visual Perception | 2 | 2004 | 1392 | 0.160 |
Why?
|
Aphasia | 2 | 2010 | 193 | 0.150 |
Why?
|
Trinucleotide Repeats | 1 | 1999 | 257 | 0.150 |
Why?
|
Aged | 48 | 2023 | 171319 | 0.150 |
Why?
|
F2-Isoprostanes | 1 | 2018 | 35 | 0.150 |
Why?
|
Cathartics | 2 | 2010 | 129 | 0.150 |
Why?
|
Medial Forebrain Bundle | 1 | 2018 | 42 | 0.150 |
Why?
|
Carboplatin | 1 | 2020 | 790 | 0.140 |
Why?
|
Female | 75 | 2023 | 396660 | 0.140 |
Why?
|
Oxidative Stress | 2 | 2019 | 3139 | 0.140 |
Why?
|
Diencephalon | 1 | 2017 | 54 | 0.140 |
Why?
|
Algorithms | 7 | 2015 | 14098 | 0.140 |
Why?
|
Language Tests | 2 | 2010 | 191 | 0.140 |
Why?
|
Endpoint Determination | 2 | 2018 | 592 | 0.140 |
Why?
|
Eye Movements | 1 | 2000 | 510 | 0.140 |
Why?
|
Abscess | 1 | 2000 | 606 | 0.140 |
Why?
|
Osteolysis | 1 | 2018 | 274 | 0.130 |
Why?
|
Alzheimer Disease | 10 | 2000 | 8717 | 0.130 |
Why?
|
Internet | 2 | 2020 | 3114 | 0.130 |
Why?
|
Eyelids | 1 | 1999 | 278 | 0.130 |
Why?
|
Genetic Association Studies | 4 | 2020 | 2744 | 0.130 |
Why?
|
Visual Cortex | 1 | 2004 | 1081 | 0.130 |
Why?
|
Putamen | 4 | 1996 | 288 | 0.130 |
Why?
|
Neuropsychology | 1 | 1997 | 110 | 0.130 |
Why?
|
Heterocyclic Compounds | 2 | 1997 | 245 | 0.130 |
Why?
|
Oncology Service, Hospital | 1 | 2016 | 55 | 0.130 |
Why?
|
Germ-Line Mutation | 3 | 2020 | 1885 | 0.120 |
Why?
|
Obsessive-Compulsive Disorder | 6 | 1996 | 1495 | 0.120 |
Why?
|
Software | 6 | 2022 | 4472 | 0.120 |
Why?
|
Cognition | 2 | 2010 | 7059 | 0.120 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 833 | 0.120 |
Why?
|
Reference Values | 8 | 2004 | 4918 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4357 | 0.110 |
Why?
|
Case-Control Studies | 9 | 2021 | 22254 | 0.110 |
Why?
|
Organometallic Compounds | 2 | 1997 | 648 | 0.110 |
Why?
|
Schwann Cells | 1 | 2014 | 195 | 0.110 |
Why?
|
Attention | 2 | 2019 | 2413 | 0.100 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2014 | 138 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 2 | 1997 | 1429 | 0.100 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13650 | 0.100 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2013 | 133 | 0.100 |
Why?
|
Emotions | 2 | 2019 | 2760 | 0.100 |
Why?
|
Fibrinolytic Agents | 3 | 2018 | 2079 | 0.100 |
Why?
|
Breast Neoplasms | 5 | 2023 | 21178 | 0.100 |
Why?
|
Analysis of Variance | 4 | 2010 | 6215 | 0.100 |
Why?
|
S100 Proteins | 1 | 2012 | 216 | 0.100 |
Why?
|
Gadolinium | 2 | 1997 | 964 | 0.100 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 409 | 0.100 |
Why?
|
Perfusion Imaging | 2 | 2010 | 193 | 0.100 |
Why?
|
Shoulder Joint | 1 | 2018 | 745 | 0.100 |
Why?
|
Epothilones | 1 | 2011 | 42 | 0.090 |
Why?
|
Pattern Recognition, Automated | 2 | 2015 | 987 | 0.090 |
Why?
|
Neuropsychological Tests | 6 | 2021 | 7121 | 0.090 |
Why?
|
Receptor, erbB-2 | 2 | 2013 | 2599 | 0.090 |
Why?
|
Reproducibility of Results | 9 | 2017 | 20169 | 0.090 |
Why?
|
Anisotropy | 2 | 2018 | 1289 | 0.090 |
Why?
|
Benzothiazoles | 1 | 2011 | 244 | 0.090 |
Why?
|
Prefrontal Cortex | 2 | 2019 | 2224 | 0.090 |
Why?
|
Neurons | 1 | 2009 | 9517 | 0.080 |
Why?
|
Kidney Function Tests | 1 | 2012 | 683 | 0.080 |
Why?
|
Nerve Growth Factors | 1 | 2012 | 564 | 0.080 |
Why?
|
Receptor, Muscarinic M1 | 1 | 2009 | 25 | 0.080 |
Why?
|
Tetrazolium Salts | 1 | 2009 | 92 | 0.080 |
Why?
|
Intracranial Arterial Diseases | 1 | 2009 | 22 | 0.080 |
Why?
|
Adolescent | 14 | 2022 | 89046 | 0.080 |
Why?
|
Collateral Circulation | 1 | 2010 | 289 | 0.080 |
Why?
|
Muscarinic Agonists | 1 | 2009 | 91 | 0.080 |
Why?
|
Carbachol | 1 | 2009 | 223 | 0.080 |
Why?
|
Atrophy | 8 | 2016 | 1631 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2009 | 152 | 0.080 |
Why?
|
Prospective Studies | 14 | 2022 | 54886 | 0.080 |
Why?
|
Intelligence | 2 | 2017 | 925 | 0.080 |
Why?
|
Sensitivity and Specificity | 9 | 2012 | 14672 | 0.080 |
Why?
|
Young Adult | 11 | 2022 | 59980 | 0.080 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 521 | 0.070 |
Why?
|
Aging | 2 | 1999 | 8729 | 0.070 |
Why?
|
Central Nervous System | 1 | 2015 | 1345 | 0.070 |
Why?
|
Basilar Artery | 1 | 2008 | 207 | 0.070 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 112 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 951 | 0.070 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 440 | 0.070 |
Why?
|
Ear Neoplasms | 1 | 2008 | 118 | 0.070 |
Why?
|
Intracranial Thrombosis | 1 | 2008 | 109 | 0.070 |
Why?
|
Regional Blood Flow | 5 | 2000 | 1479 | 0.070 |
Why?
|
Treatment Outcome | 13 | 2023 | 65295 | 0.070 |
Why?
|
Temporal Lobe | 4 | 2004 | 1717 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2010 | 515 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2666 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 616 | 0.070 |
Why?
|
Infusions, Intravenous | 3 | 2013 | 2227 | 0.070 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 638 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2010 | 743 | 0.070 |
Why?
|
Radiology | 1 | 2020 | 2106 | 0.070 |
Why?
|
Brain Injuries | 1 | 2018 | 2053 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2014 | 2028 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3851 | 0.060 |
Why?
|
Communication Disorders | 1 | 2006 | 50 | 0.060 |
Why?
|
Patient Selection | 1 | 2018 | 4256 | 0.060 |
Why?
|
Pneumothorax | 1 | 2009 | 393 | 0.060 |
Why?
|
Vocabulary | 1 | 2006 | 166 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2783 | 0.060 |
Why?
|
Visual Fields | 2 | 2004 | 1063 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4045 | 0.060 |
Why?
|
Memory | 2 | 2020 | 2192 | 0.060 |
Why?
|
Sex Factors | 6 | 2021 | 10622 | 0.060 |
Why?
|
Protein Kinase C | 1 | 2009 | 1206 | 0.060 |
Why?
|
Verbal Behavior | 2 | 2004 | 328 | 0.060 |
Why?
|
Kidney | 2 | 2012 | 7063 | 0.060 |
Why?
|
Aged, 80 and over | 15 | 2018 | 59548 | 0.060 |
Why?
|
Aphasia, Broca | 1 | 2004 | 52 | 0.060 |
Why?
|
Dominance, Cerebral | 3 | 1995 | 616 | 0.060 |
Why?
|
Mandibular Advancement | 1 | 2004 | 64 | 0.060 |
Why?
|
Cochlear Implantation | 1 | 2008 | 317 | 0.060 |
Why?
|
Observer Variation | 5 | 2006 | 2616 | 0.060 |
Why?
|
Child | 10 | 2022 | 80771 | 0.060 |
Why?
|
Acute Disease | 6 | 2010 | 7236 | 0.050 |
Why?
|
HIV Seropositivity | 3 | 1994 | 963 | 0.050 |
Why?
|
Consensus | 2 | 2011 | 3207 | 0.050 |
Why?
|
Cohort Studies | 8 | 2018 | 41718 | 0.050 |
Why?
|
Psychomotor Performance | 2 | 2010 | 1886 | 0.050 |
Why?
|
Wakefulness | 1 | 2010 | 1282 | 0.050 |
Why?
|
Occipital Lobe | 1 | 2004 | 376 | 0.050 |
Why?
|
Quality of Life | 4 | 2022 | 13485 | 0.050 |
Why?
|
Archives | 1 | 2022 | 15 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2055 | 0.050 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2008 | 783 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4745 | 0.050 |
Why?
|
Semantics | 1 | 2006 | 609 | 0.050 |
Why?
|
Thiazoles | 1 | 2009 | 1530 | 0.050 |
Why?
|
Osteogenesis, Distraction | 1 | 2004 | 233 | 0.050 |
Why?
|
Blotting, Western | 1 | 2009 | 5022 | 0.050 |
Why?
|
Brain Diseases | 3 | 1997 | 1551 | 0.050 |
Why?
|
Gyrus Cinguli | 1 | 2008 | 1118 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11872 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15424 | 0.050 |
Why?
|
Educational Status | 2 | 2008 | 2511 | 0.050 |
Why?
|
Astrocytes | 1 | 2009 | 1352 | 0.050 |
Why?
|
Tomography, Emission-Computed | 3 | 1996 | 1007 | 0.050 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2001 | 120 | 0.050 |
Why?
|
Time Factors | 6 | 2014 | 40154 | 0.040 |
Why?
|
Angiography | 1 | 2006 | 1597 | 0.040 |
Why?
|
Craniofacial Abnormalities | 1 | 2003 | 320 | 0.040 |
Why?
|
Globus Pallidus | 3 | 2003 | 247 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 18063 | 0.040 |
Why?
|
Living Donors | 1 | 2005 | 647 | 0.040 |
Why?
|
Radius Fractures | 1 | 2006 | 515 | 0.040 |
Why?
|
Colon | 1 | 2008 | 1797 | 0.040 |
Why?
|
Recovery of Function | 1 | 2010 | 2978 | 0.040 |
Why?
|
Glioma | 1 | 2015 | 3502 | 0.040 |
Why?
|
Neural Pathways | 2 | 2017 | 3078 | 0.040 |
Why?
|
Audiometry, Pure-Tone | 2 | 2012 | 210 | 0.040 |
Why?
|
Technetium Tc 99m Exametazime | 3 | 1996 | 61 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5947 | 0.040 |
Why?
|
Mutation | 3 | 2016 | 30211 | 0.040 |
Why?
|
Mandible | 1 | 2004 | 748 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2495 | 0.040 |
Why?
|
Disease Progression | 4 | 2023 | 13646 | 0.040 |
Why?
|
Organotechnetium Compounds | 3 | 1996 | 134 | 0.040 |
Why?
|
Reaction Time | 1 | 2006 | 2086 | 0.040 |
Why?
|
Speech | 1 | 2004 | 555 | 0.040 |
Why?
|
Diplopia | 1 | 2000 | 217 | 0.040 |
Why?
|
Schizophrenia | 5 | 1997 | 6977 | 0.040 |
Why?
|
Nuclear Family | 1 | 1999 | 311 | 0.040 |
Why?
|
Vision, Binocular | 1 | 2000 | 225 | 0.040 |
Why?
|
Preoperative Care | 3 | 2005 | 2252 | 0.040 |
Why?
|
Alprazolam | 1 | 1998 | 103 | 0.040 |
Why?
|
Face | 1 | 2004 | 1029 | 0.040 |
Why?
|
Parietal Lobe | 3 | 2019 | 861 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2014 | 18989 | 0.040 |
Why?
|
Oximes | 3 | 1996 | 305 | 0.040 |
Why?
|
Cognition Disorders | 3 | 1998 | 3968 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6550 | 0.040 |
Why?
|
Retrospective Studies | 9 | 2012 | 81659 | 0.040 |
Why?
|
Osteogenesis | 1 | 2004 | 1285 | 0.040 |
Why?
|
Photic Stimulation | 1 | 2004 | 1989 | 0.040 |
Why?
|
Fluoxetine | 2 | 1991 | 733 | 0.040 |
Why?
|
Cerebral Ventricles | 2 | 2017 | 550 | 0.040 |
Why?
|
Facial Expression | 1 | 2021 | 515 | 0.040 |
Why?
|
Schizophrenic Psychology | 2 | 1995 | 1647 | 0.030 |
Why?
|
Iopamidol | 2 | 2007 | 188 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2001 | 968 | 0.030 |
Why?
|
Radiography | 2 | 2020 | 6975 | 0.030 |
Why?
|
Behavior | 1 | 2019 | 538 | 0.030 |
Why?
|
Mental Disorders | 2 | 1998 | 6873 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3511 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11063 | 0.030 |
Why?
|
Pain Measurement | 2 | 2018 | 3584 | 0.030 |
Why?
|
Anti-Anxiety Agents | 1 | 1998 | 405 | 0.030 |
Why?
|
Severity of Illness Index | 6 | 2010 | 15925 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 123 | 0.030 |
Why?
|
Regression Analysis | 3 | 2000 | 6331 | 0.030 |
Why?
|
Drainage | 1 | 2000 | 1183 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16718 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5693 | 0.030 |
Why?
|
Age Factors | 6 | 2012 | 18401 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 2850 | 0.030 |
Why?
|
Echo-Planar Imaging | 1 | 1998 | 648 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11217 | 0.030 |
Why?
|
Xenon Radioisotopes | 1 | 1993 | 31 | 0.030 |
Why?
|
Postoperative Care | 1 | 2000 | 1480 | 0.030 |
Why?
|
Prognosis | 5 | 2014 | 29963 | 0.030 |
Why?
|
Hearing Loss | 2 | 2012 | 785 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 615 | 0.030 |
Why?
|
Rats | 1 | 2009 | 23713 | 0.030 |
Why?
|
Fourier Analysis | 1 | 1994 | 435 | 0.030 |
Why?
|
Swine | 3 | 2009 | 5987 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 548 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 810 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3468 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2013 | 6844 | 0.020 |
Why?
|
Meningioma | 2 | 2011 | 1219 | 0.020 |
Why?
|
Breast | 1 | 2020 | 1972 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2022 | 39317 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1733 | 0.020 |
Why?
|
Joint Instability | 1 | 2018 | 803 | 0.020 |
Why?
|
Physostigmine | 1 | 1991 | 50 | 0.020 |
Why?
|
Ischemia | 1 | 2019 | 1905 | 0.020 |
Why?
|
Orbital Neoplasms | 1 | 1992 | 223 | 0.020 |
Why?
|
Receptors, Dopamine D2 | 1 | 1993 | 471 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6310 | 0.020 |
Why?
|
Animals | 7 | 2018 | 168965 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6513 | 0.020 |
Why?
|
Surgical Flaps | 1 | 1999 | 1680 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2005 | 4268 | 0.020 |
Why?
|
Auditory Brain Stem Implants | 1 | 2009 | 33 | 0.020 |
Why?
|
Affect | 2 | 1998 | 1494 | 0.020 |
Why?
|
Pilot Projects | 3 | 2017 | 8732 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 2010 | 265 | 0.020 |
Why?
|
Multivariate Analysis | 3 | 2010 | 12069 | 0.020 |
Why?
|
Reperfusion | 1 | 2010 | 268 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 570 | 0.020 |
Why?
|
Cocaine | 1 | 1993 | 944 | 0.020 |
Why?
|
Genetic Markers | 1 | 1994 | 2602 | 0.020 |
Why?
|
Normal Distribution | 1 | 2008 | 267 | 0.020 |
Why?
|
Decision Trees | 2 | 2000 | 508 | 0.020 |
Why?
|
HIV Infections | 1 | 1994 | 17542 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 30238 | 0.020 |
Why?
|
X-Rays | 1 | 2008 | 311 | 0.020 |
Why?
|
Risk | 1 | 1999 | 9606 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2531 | 0.020 |
Why?
|
Standard of Care | 1 | 2011 | 569 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13284 | 0.020 |
Why?
|
Auditory Threshold | 1 | 2008 | 369 | 0.020 |
Why?
|
Curriculum | 1 | 2020 | 3786 | 0.020 |
Why?
|
Hemodynamics | 1 | 1997 | 4186 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2009 | 369 | 0.020 |
Why?
|
Population Surveillance | 1 | 2016 | 2594 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2010 | 1587 | 0.020 |
Why?
|
Technology, Radiologic | 1 | 2006 | 159 | 0.020 |
Why?
|
Linear Models | 2 | 2007 | 5875 | 0.020 |
Why?
|
Glioblastoma | 1 | 2001 | 3461 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 793 | 0.020 |
Why?
|
Child, Preschool | 2 | 2016 | 42606 | 0.020 |
Why?
|
Vestibular Diseases | 1 | 2008 | 232 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13035 | 0.020 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2006 | 171 | 0.020 |
Why?
|
Ear, Inner | 1 | 2009 | 426 | 0.020 |
Why?
|
Renal Veins | 1 | 2005 | 103 | 0.010 |
Why?
|
Casts, Surgical | 1 | 2006 | 184 | 0.010 |
Why?
|
Cochlear Implants | 1 | 2009 | 342 | 0.010 |
Why?
|
HIV-1 | 2 | 1993 | 6951 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2011 | 1029 | 0.010 |
Why?
|
Research Design | 2 | 2011 | 6210 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1331 | 0.010 |
Why?
|
Fracture Fixation | 1 | 2006 | 370 | 0.010 |
Why?
|
Reference Standards | 1 | 2007 | 1011 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 1996 | 12986 | 0.010 |
Why?
|
HIV Seronegativity | 2 | 1995 | 209 | 0.010 |
Why?
|
Renal Artery | 1 | 2005 | 355 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3591 | 0.010 |
Why?
|
Lymphoma | 1 | 1992 | 1896 | 0.010 |
Why?
|
Colonic Polyps | 1 | 2008 | 557 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2000 | 7435 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1999 | 14766 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2870 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9360 | 0.010 |
Why?
|
Fixation, Ocular | 1 | 2004 | 243 | 0.010 |
Why?
|
Causality | 1 | 2008 | 1253 | 0.010 |
Why?
|
Swine, Miniature | 1 | 2004 | 972 | 0.010 |
Why?
|
Radiosurgery | 1 | 2011 | 1330 | 0.010 |
Why?
|
Models, Neurological | 1 | 2010 | 1747 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2008 | 1319 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2000 | 7469 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 16036 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8068 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4892 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2013 | 3944 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8351 | 0.010 |
Why?
|
Somatosensory Cortex | 1 | 2004 | 506 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3464 | 0.010 |
Why?
|
Meningeal Neoplasms | 1 | 2009 | 1253 | 0.010 |
Why?
|
Indans | 1 | 2000 | 92 | 0.010 |
Why?
|
Colonoscopy | 1 | 2008 | 1409 | 0.010 |
Why?
|
Bipolar Disorder | 2 | 1994 | 5130 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2014 | 2215 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2008 | 2487 | 0.010 |
Why?
|
United States | 3 | 2009 | 72971 | 0.010 |
Why?
|
Nootropic Agents | 1 | 2000 | 159 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3618 | 0.010 |
Why?
|
Pain | 1 | 2014 | 5101 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18330 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3724 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10455 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9660 | 0.010 |
Why?
|
Transcription Factors | 1 | 2018 | 12158 | 0.010 |
Why?
|
Infant | 1 | 2000 | 36485 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9513 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 2721 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2001 | 1374 | 0.010 |
Why?
|
Mortality | 1 | 2008 | 2909 | 0.010 |
Why?
|
Markov Chains | 1 | 2000 | 976 | 0.010 |
Why?
|
Demography | 1 | 2001 | 1641 | 0.010 |
Why?
|
Computer Simulation | 1 | 2010 | 6260 | 0.010 |
Why?
|
Motor Cortex | 1 | 2004 | 1005 | 0.010 |
Why?
|
Models, Economic | 1 | 2000 | 719 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1993 | 4422 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8535 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2000 | 5537 | 0.010 |
Why?
|
Cost Savings | 1 | 2001 | 904 | 0.010 |
Why?
|
Blood Glucose | 1 | 1991 | 6421 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26325 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10582 | 0.010 |
Why?
|
Risk Factors | 2 | 2013 | 74886 | 0.010 |
Why?
|
Chronic Disease | 2 | 2004 | 9362 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1996 | 781 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2000 | 1741 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5098 | 0.010 |
Why?
|
Prevalence | 1 | 2010 | 15851 | 0.010 |
Why?
|
Homosexuality | 1 | 1993 | 269 | 0.010 |
Why?
|
Oxygen | 1 | 2004 | 4252 | 0.010 |
Why?
|
Mental Status Schedule | 1 | 1993 | 315 | 0.010 |
Why?
|
Thinking | 1 | 1995 | 320 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 1993 | 291 | 0.010 |
Why?
|
Piperidines | 1 | 2000 | 1667 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1998 | 2105 | 0.010 |
Why?
|
Double-Blind Method | 2 | 1998 | 12451 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1996 | 700 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 1996 | 1364 | 0.010 |
Why?
|
Amphetamines | 1 | 1991 | 142 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1991 | 322 | 0.010 |
Why?
|
Psychological Tests | 1 | 1992 | 642 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3344 | 0.010 |
Why?
|
Anthropometry | 1 | 1994 | 1345 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2001 | 3561 | 0.000 |
Why?
|
Organ Specificity | 1 | 1993 | 1966 | 0.000 |
Why?
|
Immunophenotyping | 1 | 1992 | 1864 | 0.000 |
Why?
|
Health Care Costs | 1 | 2000 | 3239 | 0.000 |
Why?
|
Homosexuality, Male | 1 | 1995 | 1344 | 0.000 |
Why?
|
Anxiety | 2 | 1991 | 4670 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1996 | 4780 | 0.000 |
Why?
|
Social Class | 1 | 1994 | 2007 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6023 | 0.000 |
Why?
|
Glucose | 1 | 1996 | 4341 | 0.000 |
Why?
|
Amygdala | 1 | 1992 | 1375 | 0.000 |
Why?
|
Radiation Dosage | 1 | 1992 | 1965 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1991 | 4855 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1991 | 10748 | 0.000 |
Why?
|